Epidemiological Characteristics of Pediatric Patients with Intestinal Failure in Spain: Data from the REPAFI Registry

Marta Germán-Díaz1, Rocío González-Sacristán2, Vanessa Cabello3

  • 1Pediatric Gastroenterology, Hepatology and Nutrition Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Nutrients
|December 11, 2025
PubMed

Insights

This study reveals that short bowel syndrome is the primary cause of pediatric chronic intestinal failure in Spain. Patients with congenital enteropathies experienced the most severe malnutrition upon starting home parenteral nutrition.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Clinical Nutrition

Background:

  • Limited data exists on the epidemiology of pediatric chronic intestinal failure (CIF).
  • Understanding CIF's scope in Spain is crucial for public health initiatives.
  • This study addresses the paucity of epidemiological data on pediatric CIF in Spain.

Purpose of the Study:

  • To comprehensively describe the epidemiology of pediatric CIF in Spain.
  • To detail incidence, geographical distribution, causes, and patient characteristics.
  • To establish a baseline for future research and clinical interventions.

Main Methods:

  • A national, multicenter, ambispective cohort study was conducted.
  • Data from patients initiating home parenteral nutrition (HPN) between 2015-2025 were analyzed.
  • Demographics, diagnoses, HPN type, and nutritional status were recorded.

Main Results:

  • 163 pediatric patients from 10 hospitals were included.
  • Short bowel syndrome (SBS) was the leading cause (77.3%), followed by motility disorders (12.9%) and congenital enteropathies (CE) (5.5%).
  • SBS patients had lower gestational age/birthweight; CE patients showed the most severe malnutrition at HPN initiation.

Conclusions:

  • This study presents the first epidemiological data on pediatric CIF in Spain.
  • Short bowel syndrome is the predominant cause, with earlier HPN initiation compared to international data.
  • Congenital enteropathies are associated with the most severe malnutrition at HPN onset.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
614
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
382